H.MoradiB.et al (2024)
HEK293 C24 cells stably expressing the H188 FRET reporter were obtained by G418 selection and grown in monolayers to 70% confluency in 100 cm 2 tissue culture dishes and were then transfected with plasmids (11 g/dish) encoding human GLP-1R, human Y2-R, or human Y1-R
Phase II trials for tirzepatide and survodutide, a GLP-1/glucagon receptor co-agonist, have also shown positive outcomes in people living with MASH and obesity, demonstrating reduction of inflammation without worsening of fibrosis (4, 69)
View Protocol Complete dosage protocol and reconstitution guide for GHRP-6 (2 mg Vial)
Contains glutathione precursors to support natural antioxidant production
You'll receive clear communication about medication options, insurance coverage, and treatment costs, ensuring no surprises along your journey